Regulatory Blog

The Regulatory News you Need to Know,Share & Grow

USFDA Guidance: Providing Over-the-Counter Monograph Submissions in Electronic Format

The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research released a final guidance titled "Providing...

USFDA Guidance: Formal Dispute Resolution and Administrative Hearings for OTC Monograph Drugs

Today (22 June 2023) the United States Food & Drug Administration's Center for Drug Evaluation and Research released a draft guidance on...

FDA's: OTC Monograph Drug User Fees for Fiscal Year 2022

Yesterday USFDA published the fees for over-the-counter (OTC) monograph drugs for fiscal year (FY) 2022 in a Federal Register Notice...

USFDA - Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs

US Food and Drug Administration (FDA) issued draft guidance discussing formal meetings between sponsors of over-the-counter (OTC)...